Addressing conflicts of interest regarding the vaccine in infectious disease outbreaks based on good governance for health approach : a policy brief
© 2023. BioMed Central Ltd., part of Springer Nature..
BACKGROUND: Infectious disease outbreaks pose a significant threat to public health, and achieving herd immunity highlights the importance of addressing conflicts of interest (COI) in vaccine development and policy-making. This policy brief aims to present policy options that address COI regarding vaccines in infectious disease outbreaks, based on good governance for health approach.
METHODS: Our study used a scoping review methodology. We conducted a systematic search, which led to identifying 43 eligible articles. A qualitative approach (i.e., content analysis) was employed for data analysis, using "ATLAS.ti 9" software. The primary results underwent a process of cleaning, categorisation, and subsequent discussion in three sessions with the research team.
RESULTS: Relationships between theindustry and "government/policymakers" as well as "academic institutions/researchers" are prominent origins of COI regarding the vaccine in infectious disease outbreaks. To address this issue, we present nine policy options that target both the root cause of the problem and the adoption of good governance for health approach.
CONCLUSIONS: The key principles of good governance for health, including, "Transparency", "The Rule of Law", "Effectiveness", "Efficiency", "Participation", "Consensus Orientation", "Equality", "Responsibility", "Responsiveness" and "Accountability" must be taken into account when formulating policy options to address COI regarding the vaccine in infectious disease outbreaks. The effectiveness of the policy options outlined in this policy brief should be assessed in practical contexts, as this evaluation may uncover the need for revisions.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
---|---|
Enthalten in: |
BMC health services research - 23(2023), 1 vom: 25. Sept., Seite 1028 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Soleimani, Nazanin [VerfasserIn] |
---|
Links: |
---|
Themen: |
Conflicts of interest |
---|
Anmerkungen: |
Date Completed 27.09.2023 Date Revised 27.02.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/s12913-023-10020-w |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM362459169 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM362459169 | ||
003 | DE-627 | ||
005 | 20240229163629.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s12913-023-10020-w |2 doi | |
028 | 5 | 2 | |a pubmed24n1308.xml |
035 | |a (DE-627)NLM362459169 | ||
035 | |a (NLM)37749540 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Soleimani, Nazanin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Addressing conflicts of interest regarding the vaccine in infectious disease outbreaks based on good governance for health approach |b a policy brief |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.09.2023 | ||
500 | |a Date Revised 27.02.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. BioMed Central Ltd., part of Springer Nature. | ||
520 | |a BACKGROUND: Infectious disease outbreaks pose a significant threat to public health, and achieving herd immunity highlights the importance of addressing conflicts of interest (COI) in vaccine development and policy-making. This policy brief aims to present policy options that address COI regarding vaccines in infectious disease outbreaks, based on good governance for health approach | ||
520 | |a METHODS: Our study used a scoping review methodology. We conducted a systematic search, which led to identifying 43 eligible articles. A qualitative approach (i.e., content analysis) was employed for data analysis, using "ATLAS.ti 9" software. The primary results underwent a process of cleaning, categorisation, and subsequent discussion in three sessions with the research team | ||
520 | |a RESULTS: Relationships between theindustry and "government/policymakers" as well as "academic institutions/researchers" are prominent origins of COI regarding the vaccine in infectious disease outbreaks. To address this issue, we present nine policy options that target both the root cause of the problem and the adoption of good governance for health approach | ||
520 | |a CONCLUSIONS: The key principles of good governance for health, including, "Transparency", "The Rule of Law", "Effectiveness", "Efficiency", "Participation", "Consensus Orientation", "Equality", "Responsibility", "Responsiveness" and "Accountability" must be taken into account when formulating policy options to address COI regarding the vaccine in infectious disease outbreaks. The effectiveness of the policy options outlined in this policy brief should be assessed in practical contexts, as this evaluation may uncover the need for revisions | ||
650 | 4 | |a Review | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Conflicts of interest | |
650 | 4 | |a Good governance for health | |
650 | 4 | |a Infectious disease outbreaks | |
650 | 4 | |a Vaccine | |
650 | 7 | |a Vaccines |2 NLM | |
700 | 1 | |a Ghoshouni, Hamed |e verfasserin |4 aut | |
700 | 1 | |a Mostafavi, Hakimeh |e verfasserin |4 aut | |
700 | 1 | |a Modiri, Mohammad Hossein |e verfasserin |4 aut | |
700 | 1 | |a Attar, Mohammad Hasan Movahedian |e verfasserin |4 aut | |
700 | 1 | |a Mousavi, Seyed Masood |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMC health services research |d 2001 |g 23(2023), 1 vom: 25. Sept., Seite 1028 |w (DE-627)NLM111682703 |x 1472-6963 |7 nnns |
773 | 1 | 8 | |g volume:23 |g year:2023 |g number:1 |g day:25 |g month:09 |g pages:1028 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12913-023-10020-w |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 23 |j 2023 |e 1 |b 25 |c 09 |h 1028 |